IT vs STRO
Gartner Inc (IT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
IT currently screens at market cap $11.03B and trailing P/E 16.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the IT and STRO stock pages for the full models.
Not investment advice.